C M Hustad
Overview
Explore the profile of C M Hustad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
625
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barrett-Connor E, Swern A, Hustad C, Bone H, Liberman U, Papapoulos S, et al.
Osteoporos Int
. 2011 Mar;
23(1):233-45.
PMID: 21369791
Unlabelled: In this meta-analysis of all Merck-conducted, placebo-controlled clinical trials of alendronate, the occurrence of AF was uncommon, with most studies reporting two or fewer events. Across all studies, no...
2.
Reid D, Hosking D, Kendler D, Brandi M, Wark J, Marques-Neto J, et al.
Int J Clin Pract
. 2008 Mar;
62(4):575-84.
PMID: 18324951
Objectives: To compare alendronate 70 mg once weekly (OW) with risedronate 35 mg OW with respect to change in bone mineral density (BMD), biochemical markers and upper gastrointestinal (UGI) tolerability...
3.
Cady R, Martin V, Mauskop A, Rodgers A, Hustad C, Ramsey K, et al.
Cephalalgia
. 2007 Aug;
27(9):1055-60.
PMID: 17681023
The presence of cutaneous allodynia may predict response to triptans. Identical randomized double-blind studies were conducted comparing the efficacy of rizatriptan 10 mg or placebo administered within 1 h of...
4.
Mannix L, Loder E, Nett R, Mueller L, Rodgers A, Hustad C, et al.
Cephalalgia
. 2007 Apr;
27(5):414-21.
PMID: 17448179
These are the first prospective studies to use criteria for menstrual migraine proposed in the 2004 revision of the International Classification of Headache Disorders (ICHD-II) to examine the efficacy of...
5.
Peters-Golden M, Swern A, Bird S, Hustad C, Grant E, Edelman J
Eur Respir J
. 2006 Mar;
27(3):495-503.
PMID: 16507848
The incidence of asthma has been positively associated with obesity. Asthma comprises diverse "phenotypes" reflecting heterogeneity in a number of characteristics, including response to therapy. The present authors examined whether...
6.
Kalman K, Nguyen A, Dukes I, Chandy G, Hustad C, Copeland N, et al.
J Biol Chem
. 1998 Apr;
273(10):5851-7.
PMID: 9488722
We report the isolation of a novel mouse voltage-gated Shaker-related K+ channel gene, Kv1.7 (Kcna7/KCNA7). Unlike other known Kv1 family genes that have intronless coding regions, the protein-coding region of...
7.
Perry W, Hustad C, Swing D, OSullivan T, Jenkins N, Copeland N
Nat Genet
. 1998 Feb;
18(2):143-6.
PMID: 9462742
Non-agouti-lethal 18H (a18H) mice are dark agouti with black pinna hairs. What makes these mice unique is that they develop a spectrum of immunological diseases not seen in other agouti...
8.
Perry W, Nakamura T, Swing D, Secrest L, Eagleson B, Hustad C, et al.
Genetics
. 1996 Sep;
144(1):255-64.
PMID: 8878691
The agouti locus encodes a novel paracrine signaling molecule containing a signal sequence, an N-linked glycosylation site, a central lysine-rich basic domain, and a C-terminal tail containing 10 cysteine (Cys)...
9.
Molkentin J, Firulli A, Black B, Martin J, Hustad C, Copeland N, et al.
Mol Cell Biol
. 1996 Jul;
16(7):3814-24.
PMID: 8668199
There are four members of the myocyte enhancer binding factor 2 (MEF2) family of transcription factors, MEF2A, -B, -C, and -D, that have homology within an amino-terminal MADS box and...
10.
Perry W, Hustad C, Swing D, Jenkins N, Copeland N
Genetics
. 1995 May;
140(1):267-74.
PMID: 7635291
The mouse agouti gene encodes an 131 amino acid paracrine signaling molecule that instructs hair follicle melanocytes to switch from making black to yellow pigment. Expression of agouti during the...